KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Work In Process (2018 - 2022)

TherapeuticsMD (TXMD) has disclosed Work In Process for 5 consecutive years, with $218000.0 as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Work In Process fell 68.31% year-over-year to $218000.0, compared with a TTM value of $218000.0 through Sep 2022, down 68.31%, and an annual FY2021 reading of $1.6 million, up 83.46% over the prior year.
  • Work In Process was $218000.0 for Q3 2022 at TherapeuticsMD, down from $1.7 million in the prior quarter.
  • Across five years, Work In Process topped out at $1.7 million in Q2 2022 and bottomed at $83911.0 in Q3 2018.
  • Average Work In Process over 5 years is $849310.4, with a median of $808694.0 recorded in 2019.
  • The sharpest move saw Work In Process surged 1098.38% in 2019, then plummeted 68.31% in 2022.
  • Year by year, Work In Process stood at $339312.0 in 2018, then soared by 248.37% to $1.2 million in 2019, then dropped by 24.28% to $895000.0 in 2020, then soared by 83.46% to $1.6 million in 2021, then tumbled by 86.72% to $218000.0 in 2022.
  • Business Quant data shows Work In Process for TXMD at $218000.0 in Q3 2022, $1.7 million in Q2 2022, and $1.2 million in Q1 2022.